Center for Breakthrough Medicines‘ headquarters at the Discovery Labs, King of Prussia, PA. (Center for Breakthrough Medicines)

Cen­ter for Break­through Med­i­cines plans for an even larg­er dive in­to cell ther­a­py man­u­fac­tur­ing

As the pipeline for cell ther­a­pies grows, man­u­fac­tur­ers and CD­MOs are look­ing to get in on the ac­tion.

The Cen­ter for Break­through Med­i­cines, a Penn­syl­va­nia-based CD­MO, is part­ner­ing with Dis­cov­ery Labs to ac­cel­er­ate plans to build the ca­pac­i­ty to man­u­fac­ture more than 10,000 pa­tient ther­a­pies at their head­quar­ters in King of Prus­sia, PA, a sub­urb of Philadel­phia.

The plan­ning has be­gun on the man­u­fac­tur­ing suites and sup­port­ing in­fra­struc­ture, and when com­plet­ed the fa­cil­i­ty, ac­cord­ing to CBM’s con­ser­v­a­tive cal­cu­la­tions, the site will be able to pro­duce around 10,000 batch­es of prod­uct per year in the space.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.